indolepropanol phosphate has been researched along with Glioblastoma in 1 studies
indolepropanol phosphate: binds specifically to the alpha subunit, but not to the beta subunit of tryptophan synthase
3-(indol-3-yl)propyl phosphate : An monoalkyl phosphate compound having an O-3-(indol-3-yl)propyl substituent.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SH | 1 |
| Kwon, HJ | 1 |
| Park, S | 1 |
| Kim, CI | 1 |
| Ryu, H | 1 |
| Kim, SS | 1 |
| Park, JB | 1 |
| Kwon, JT | 1 |
1 other study available for indolepropanol phosphate and Glioblastoma
| Article | Year |
|---|---|
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
Topics: Animals; Brain Neoplasms; Cell Proliferation; Glioblastoma; Humans; Immunohistochemistry; Indoles; M | 2021 |